EUVIMEDEUVIMED entdecken
Crossref

Pathogen‐Mimicking Nanoparticles Based on Rigid Nanomaterials as an Efficient Subunit Vaccine Delivery System for Intranasal Immunization

Hongping Wan iD, Kai Deng, Zhengqun Huang, Yunhan Yang, Bo Jing, Yumei Feng, Yuanfeng Li, Yong Liu, Mingqin Lu, Xinghong Zhao iD

Advanced Healthcare Materials · 2024-10 · 13 (26)

DOI: 10.1002/adhm.202401120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 25.06.2024. Verfasst von Hongping Wan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Diseases Control (CIDC), Sichuan Agricultural University, Chengdu, 611130, China. Hauptthemen laut MEDLINE: Administration, Intranasal, Nanoparticles, Vaccines, Subunit, Chitosan. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Center for Infectious Diseases Control (CIDC), Health Science and Technology Plan of Zhejiang Province, Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the safety profile of subunit vaccines, the inferior immunogenicity hinders their application in the nasal cavity. This study introduces a novel antigen delivery and adjuvant system utilizing mucoadhesive chitosan–catechol (Chic) on silica spiky nanoparticles (Ssp) to enhance immunity through multiple mechanisms. The Chic functionalizes the Ssp surface and incorporates with SARS‐CoV‐2 spike protein receptor‐binding domain (RBD) and toll‐like receptor (TLR)9 agonist unmethylated cytosine‐guanine (CpG) motif, forming uniform virus‐like nanoparticles (Ssp‐Chic‐RBD‐CpG) via electrostatic and covalent interactions. Ssp‐Chic‐RBD‐CpG, mimicking the morphology and function of inactive virions, effectively prolongs the retention time of RBD in the nasal mucosa by 3.92‐fold compared to RBD alone, enhances the maturation of dendritic cells (DCs), and facilitates the antigen trafficking to the draining lymph nodes, which subsequently induces a stronger mucosal immunity. Mechanistically, the enhanced chemokine chemokine (C‐C motif) ligand 20 (CCL20)‐driven DCs recruitment and maturation by Ssp‐Chic‐RBD‐CpG are evidenced by a cell co‐culture model. In addition, the overexpression of TLR4/9 and activation of MYD88/NF‐κB signaling pathway in activation of DCs are observed. Proof of principle is obtained for RBD, but similar delivery mechanisms can be applied in other protein‐based subunit vaccines as well when intranasal administration is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, IntranasalNanoparticlesVaccines, SubunitChitosanAnimalsMiceDendritic CellsSpike Glycoprotein, CoronavirusCOVID-19COVID-19 VaccinesFemaleSARS-CoV-2Nasal MucosaMice, Inbred BALB CMice, Inbred C57BLHumansImmunizationSilicon DioxideToll-Like Receptor 9Immunity, Mucosal

Stichwörter der Autor:innen

mucosal immunologynanodelivery systempathogen‐mimicking nanoparticlessubunit vaccine

Substanzen

Vaccines, SubunitChitosanSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 VaccinesSilicon DioxideToll-Like Receptor 9

Autor:innen und Institutionen

  • Center for Infectious Diseases Control (CIDC), Sichuan Agricultural University, Chengdu, 611130, China.
  • Key Laboratory of Animal Disease and Human Health of Sichuan Province, Sichuan Agricultural University, Chengdu, 611130, China.
  • State Key Laboratory of Crop Gene Exploration and Utilization in Southwest China, Sichuan Agricultural University at Wenjiang, Chengdu, 611130, China.
  • Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, China.
  • Translational Medicine Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, China.
  • Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, China.

ORCID-Profile: Hongping Wan, Xinghong Zhao

Förderung

  • Center for Infectious Diseases Control (CIDC)
  • Health Science and Technology Plan of Zhejiang Province
  • Sichuan Province Science and Technology Support Program
  • National Natural Science Foundation of China
  • 1000 Talents Sichuan Program

Zitieren

APA

Wan, H., Deng, K., Huang, Z., Yang, Y., Jing, B., Feng, Y., Li, Y., Liu, Y., Lu, M., & Zhao, X. (2024). Pathogen‐Mimicking Nanoparticles Based on Rigid Nanomaterials as an Efficient Subunit Vaccine Delivery System for Intranasal Immunization. Advanced Healthcare Materials, 13(26). https://doi.org/10.1002/adhm.202401120

Vancouver

Wan H, Deng K, Huang Z, Yang Y, Jing B, Feng Y, et al. Pathogen‐Mimicking Nanoparticles Based on Rigid Nanomaterials as an Efficient Subunit Vaccine Delivery System for Intranasal Immunization. Advanced Healthcare Materials. 2024;13(26). doi:10.1002/adhm.202401120

BibTeX
@article{Wan2024,
  author = {Wan, Hongping and Deng, Kai and Huang, Zhengqun and Yang, Yunhan and Jing, Bo and Feng, Yumei and Li, Yuanfeng and Liu, Yong and Lu, Mingqin and Zhao, Xinghong},
  title = {Pathogen‐Mimicking Nanoparticles Based on Rigid Nanomaterials as an Efficient Subunit Vaccine Delivery System for Intranasal Immunization},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {26},
  doi = {10.1002/adhm.202401120}
}
Kostenlos starten →